Stocks
Regentis Biomaterials Ltd.RGNT
AMEXManufacturingBiotechnology$1.47
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing regenerative tissue therapies, with a lead product candidate aimed at cartilage repair. The company is focused on advancing its proprietary hydrogel-based platform through regulatory pathways, making it a subject of interest for investors tracking orthopedic and regenerative medicine opportunities.
52W Range: $1.23-$15.50
Congressional Interest in Regentis Biomaterials Ltd. (RGNT)
No congressional trades have been disclosed for Regentis Biomaterials Ltd. (RGNT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading RGNT?
No congressional trades found for this stock.